Toroso Investments, LLC Bio Atla, Inc. Transaction History

Toroso Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.37 - $3.92 $55,808 - $159,685	-40,736 Reduced 28.06%	104,438 $143,000
Q1 2024 May 15, 2024	SELL	$1.88 - $3.46 $17,055 - $31,389	-9,072 Reduced 5.88%	145,174 $499,000
Q4 2023 Feb 14, 2024	SELL	$1.27 - $3.18 $7,680 - $19,232	-6,048 Reduced 3.77%	154,246 $379,000
Q3 2023 Nov 15, 2023	BUY	$1.7 - $3.07 $122,160 - $220,607	71,859 Added 81.26%	160,294 $272,000
Q1 2023 May 15, 2023	BUY	$2.3 - $8.25 $124,383 - $446,160	54,080 Added 157.42%	88,435 $237,000
Q4 2022 Feb 15, 2023	SELL	$6.29 - $11.01 $41,293 - $72,280	-6,565 Reduced 16.04%	34,355 $283,000
Q3 2022 Nov 23, 2022	SELL	$2.94 - $11.87 $260,457 - $1.05 Million	-88,591 Reduced 68.4%	40,920 $315,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $5.38 $275,858 - $696,769	129,511 New	129,511 $369,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Toroso Investments, LLC with notifications on news.